Nordea Investment Management
GMED icon

Nordea Investment Management’s Globus Medical GMED Stock Holding History

Nordea Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-237,648
Closed -$13.3M – 962
2023
Q1 		$13.3M Sell
237,648
-566,998
-70% -$36.4M 0.02% 337
2022
Q4 		$59.2M Sell
804,646
-271,056
-25% -$18.5M 0.09% 207
2022
Q3 		$64.8M Buy
1,075,702
+110,347
+11% +$6.65M 0.1% 191
2022
Q2 		$54M Sell
965,355
-18,206
-2% -$1.2M 0.08% 208
2022
Q1 		$73.5M Buy
983,561
+162,812
+20% +$11.3M 0.09% 203
2021
Q4 		$59.7M Buy
820,749
+110,667
+16% +$8.03M 0.07% 229
2021
Q3 		$56.5M Buy
710,082
+21,045
+3% +$1.69M 0.07% 231
2021
Q2 		$53.4M Sell
689,037
-60,265
-8% -$4.28M 0.07% 232
2021
Q1 		$46M Buy
749,302
+31,813
+4% +$2.01M 0.07% 239
2020
Q4 		$46.8M Buy
717,489
+70,440
+11% +$4.05M 0.08% 227
2020
Q3 		$31.8M Sell
647,049
-556,119
-46% -$28.7M 0.06% 236
2020
Q2 		$56.6M Buy
1,203,168
+641,351
+114% +$30.9M 0.06% 227
2020
Q1 		$23.7M Buy
561,817
+196,203
+54% +$9.69M 0.06% 231
2019
Q4 		$21.5M Buy
365,614
+46,590
+15% +$2.53M 0.04% 271
2019
Q3 		$16.3M Sell
319,024
-15,468
-5% -$737K 0.04% 283
2019
Q2 		$14.2M Buy
334,492
+14,139
+4% +$614K 0.03% 304
2019
Q1 		$15.8M Buy
320,353
+50,492
+19% +$2.28M 0.03% 319
2018
Q4 		$11.7M Buy
269,861
+63,607
+31% +$3.17M 0.03% 342
2018
Q3 		$11.7M Buy
206,254
+125,274
+155% +$6.59M 0.02% 371
2018
Q2 		$4.09M Buy
80,980
+23,328
+40% +$1.22M 0.01% 495
2018
Q1 		$2.87M Sell
57,652
-15,862
-22% -$746K 0.01% 646
2017
Q4 		$3.02M Sell
73,514
-3,955
-5% -$138K 0.01% 513
2017
Q3 		$2.3M Buy
77,469
+54,368
+235% +$1.66M 0.01% 602
2017
Q2 		$766K Sell
23,101
-6,434
-22% -$202K ﹤0.01% 806
2017
Q1 		$875K Sell
29,535
-1,868
-6% -$51K ﹤0.01% 783
2016
Q4 		$779K Sell
31,403
-2,815
-8% -$64K ﹤0.01% 791
2016
Q3 		$772K Buy
34,218
+17,956
+110% +$422K ﹤0.01% 770
2016
Q2 		$388K Buy
16,262
+14,835
+1,040% +$356K ﹤0.01% 798
2016
Q1 		$34K Buy
+1,427
New +$34.9K ﹤0.01% 950

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Nordea Investment Management's GMED Position: Q2 2023 in Review

Nordea Investment Management sold out of Globus Medical (GMED) in Q2 2023, closing a stake of 237,648 shares — an estimated $13.3M sold.

Nordea Investment Management first reported a position in GMED in Q1 2016 and held it in 29 quarters. The position peaked at $73.5M in Q1 2022. 382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • Nordea Investment Management reported no remaining Globus Medical position as of Q2 2023 after selling out during the quarter.
  • Nordea Investment Management sold 237,648 Globus Medical shares in Q2 2023, an estimated $13.3M.
  • Nordea Investment Management first reported a position in Globus Medical in Q1 2016 and held it in 29 quarters.
  • Nordea Investment Management's Globus Medical position peaked at $73.5M in Q1 2022.
  • 382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on Nordea Investment Management's 13F filing for Q2 2023, filed 7 Jul 2023.